Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Reiff

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|April 4, 2006
Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extensionAndreas Reiff, Daniel J Lovell, Janet Van Adelsberg, et al.
Arthritis and Rheumatism|May 30, 2006
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritisDaniel J Lovell, Andreas Reiff, Olcay Y Jones, et al.
Arthritis and Rheumatism|January 16, 2003
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trialDaniel J Lovell, Edward H Giannini, Andreas Reiff, et al.
Arthritis and Rheumatism|August 12, 2003
Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort studyAngelo Ravelli, Carolina Duarte-Salazar, Silvia Buratti, et al.
Arthritis and Rheumatism|June 10, 2004
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damageNicolino Ruperto, Silvia Buratti, Carolina Duarte-Salazar, et al.
Clinical and Experimental Rheumatology|July 12, 2021
Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of childrenSeza Ozen, Holly L Lutz, Vanessa M Rivera, et al.
Arthritis Research & Therapy|February 1, 2018
Age and fecal microbial strain-specific differences in patients with spondyloarthritisMatthew L Stoll, Pamela F Weiss, Jennifer E Weiss, et al.
Arthritis Care & Research|May 28, 2011
Preliminary criteria for global flares in childhood-onset systemic lupus erythematosusHermine I Brunner, Rina Mina, Clarissa Pilkington, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidaseChaim O Jacob, Miriam Eisenstein, Mary C Dinauer, et al.
The New England Journal of Medicine|August 22, 2008
Adalimumab with or without methotrexate in juvenile rheumatoid arthritisDaniel J Lovell, Nicolino Ruperto, Steven Goodman, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|April 4, 2006
Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extensionAndreas Reiff, Daniel J Lovell, Janet Van Adelsberg, et al.
Arthritis and Rheumatism|May 30, 2006
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritisDaniel J Lovell, Andreas Reiff, Olcay Y Jones, et al.
Arthritis and Rheumatism|January 16, 2003
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trialDaniel J Lovell, Edward H Giannini, Andreas Reiff, et al.
Arthritis and Rheumatism|August 12, 2003
Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort studyAngelo Ravelli, Carolina Duarte-Salazar, Silvia Buratti, et al.
Arthritis and Rheumatism|June 10, 2004
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damageNicolino Ruperto, Silvia Buratti, Carolina Duarte-Salazar, et al.
Clinical and Experimental Rheumatology|July 12, 2021
Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of childrenSeza Ozen, Holly L Lutz, Vanessa M Rivera, et al.
Arthritis Research & Therapy|February 1, 2018
Age and fecal microbial strain-specific differences in patients with spondyloarthritisMatthew L Stoll, Pamela F Weiss, Jennifer E Weiss, et al.
Arthritis Care & Research|May 28, 2011
Preliminary criteria for global flares in childhood-onset systemic lupus erythematosusHermine I Brunner, Rina Mina, Clarissa Pilkington, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidaseChaim O Jacob, Miriam Eisenstein, Mary C Dinauer, et al.
The New England Journal of Medicine|August 22, 2008
Adalimumab with or without methotrexate in juvenile rheumatoid arthritisDaniel J Lovell, Nicolino Ruperto, Steven Goodman, et al.
Pageof 5